These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10718042)

  • 1. Patient education and protection through PBMs.
    Dichter E
    Health Aff (Millwood); 2000; 19(2):271. PubMed ID: 10718042
    [No Abstract]   [Full Text] [Related]  

  • 2. PBMs: a key player in Medicare drug coverage.
    Toan BA; Scripts E
    Health Aff (Millwood); 2000; 19(2):270. PubMed ID: 10718041
    [No Abstract]   [Full Text] [Related]  

  • 3. Discussion of papers by Karen Scott Collins and Jan Blustein.
    Feder J
    Womens Health Issues; 2000; 10(2):54-6. PubMed ID: 10736557
    [No Abstract]   [Full Text] [Related]  

  • 4. Six questions to ask when eyeing Medicare pharmacy risk.
    Public Sect Contract Rep; 1998 Aug; 4(8):117-20. PubMed ID: 10182906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicare Part D: primer.
    Coakley C
    Adv Nurse Pract; 2006 Sep; 14(9):24. PubMed ID: 16972439
    [No Abstract]   [Full Text] [Related]  

  • 6. Medicare part D prescription drug benefit--part 1 of 2.
    Klein CA
    Nurse Pract; 2006 Feb; 31(2):61. PubMed ID: 16452904
    [No Abstract]   [Full Text] [Related]  

  • 7. The double edge of a Medicare drug benefit.
    Moskowitz DB
    Bus Health; 1999 Dec; 17(12):18. PubMed ID: 10787484
    [No Abstract]   [Full Text] [Related]  

  • 8. A bitter pill: the new Medicare prescription drug benefit.
    Siegel S
    Health Care Law Mon; 2005 Mar; ():3-9. PubMed ID: 15818780
    [No Abstract]   [Full Text] [Related]  

  • 9. PBMs and a Medicare prescription drug benefit.
    Cohen JP
    Food Drug Law J; 2000; 55(3):311-20. PubMed ID: 11824463
    [No Abstract]   [Full Text] [Related]  

  • 10. Will health reform reduce costs?
    Kastor JA
    Pharos Alpha Omega Alpha Honor Med Soc; 2010; 73(1):35-6. PubMed ID: 20180291
    [No Abstract]   [Full Text] [Related]  

  • 11. Medicare coverage of prescription drugs.
    Division of Advocacy and Health Policy
    Bull Am Coll Surg; 2005 Sep; 90(9):29-30, 62. PubMed ID: 18435099
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of the doughnut hole.
    Penna P
    Manag Care Interface; 2007 Sep; 20(9):49-50. PubMed ID: 18161393
    [No Abstract]   [Full Text] [Related]  

  • 13. Plans should harness PBMs to help educate customers.
    Gibson T
    Manag Care; 2003 Mar; 12(3):8, 11. PubMed ID: 12685369
    [No Abstract]   [Full Text] [Related]  

  • 14. Medicare pharmacy risk a bitter pill for the unprepared.
    Public Sect Contract Rep; 1997 Jun; 3(6):81-6. PubMed ID: 10175081
    [No Abstract]   [Full Text] [Related]  

  • 15. Specialty pharmaceuticals: developing a management plan.
    Willcutts D
    Manag Care Q; 2002; 10(4):26-9. PubMed ID: 12561391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Medicare prescription drug benefit: how will the game be played?
    Huskamp HA; Rosenthal MB; Frank RG; Newhouse JP
    Health Aff (Millwood); 2000; 19(2):8-23. PubMed ID: 10718018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managed care pharmacy: the job gets more intense.
    Belfiglio G
    Healthplan; 2003; 44(3):62-4, 66. PubMed ID: 12808762
    [No Abstract]   [Full Text] [Related]  

  • 18. Medicare risk programs and pharmacy benefits managers.
    Herzfeld J
    Med Interface; 1996 Dec; 9(12):75-8. PubMed ID: 10172875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Medicare prescription drug plan: assisting our older patients.
    Klein MN
    ORL Head Neck Nurs; 2004; 22(4):34-5. PubMed ID: 15617318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. At the helm of an insurance giant: Aetna's Richard L. Huber. Interview by James Robinson.
    Huber RL
    Health Aff (Millwood); 1999; 18(6):89-99. PubMed ID: 10650691
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.